NOSEBLEED

Clinical trials for NOSEBLEED explained in plain language.

Never miss a new study

Get alerted when new NOSEBLEED trials appear

Sign up with your email to follow new studies for NOSEBLEED, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Could a cancer pill stop debilitating nosebleeds? new trial hopes so.

Disease control Ongoing

This study tests whether a low dose of pazopanib, a drug currently used for cancer, can reduce severe nosebleeds and improve anemia in people with hereditary hemorrhagic telangiectasia (HHT). About 70 participants will take either the drug or a placebo daily for 24 weeks. Researc…

Matched conditions: NOSEBLEED

Phase: PHASE2, PHASE3 • Sponsor: Cure HHT • Aim: Disease control

Last updated Jun 27, 2026 11:03 UTC

NOSEBLEED

Get alerted when new NOSEBLEED trials appear

Could a cancer pill stop debilitating nosebleeds? new trial hopes so.